Co-Diagnostics, Inc. Logo

Co-Diagnostics, Inc.

Develops patented PCR solutions for accurate infectious disease diagnostics.

CODX | NDAQ

Overview

Corporate Details

ISIN(s):
US1897631057
LEI:
Country:
United States of America
Address:
4049 SOUTH HIGHLAND DRIVE, 84124 SALT LAKE CITY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Co-Diagnostics, Inc. is a molecular diagnostics company that develops, manufactures, and markets diagnostic technologies. The company specializes in polymerase chain reaction (PCR) testing solutions for infectious diseases, powered by its patented and proprietary Co-Primers® technology. This platform is engineered to reduce primer-dimers, which can cause inaccurate results, thereby increasing the sensitivity and specificity of tests. Co-Diagnostics offers products for various applications, including in vitro diagnostics (IVD), research use only (RUO), and vector control for mosquito-borne diseases. The company is also developing at-home and point-of-care PCR platforms to make real-time testing more accessible.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Co-Diagnostics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Co-Diagnostics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Co-Diagnostics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
cbdMD, Inc. Logo
Produces & distributes lab-tested CBD wellness products for people and pets.
United States of America YCBD
CDT Equity Inc. Logo
Clinical-stage biopharma using AI to enhance and advance therapies for unmet medical needs.
United States of America CDT
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom CEL
Celcuity Inc. Logo
Developing targeted PI3K/mTOR inhibitor therapies for breast and prostate solid tumors.
United States of America CELC
Celemics, Inc. Logo
Develops custom NGS panels and bioinformatics for research and clinical diagnostics.
South Korea 331920
Develops & manufactures radiopharmaceuticals for cancer diagnosis and therapy.
South Korea 308430
CELL BIOTECH CO ., LTD Logo
A global biotech firm offering probiotic raw materials, OEM/ODM services, and consumer brands.
South Korea 049960
Celldex Therapeutics, Inc. Logo
Develops antibody-based therapies for severe inflammatory, allergic, and autoimmune diseases.
United States of America CLDX
Cellectar Biosciences, Inc. Logo
Late-stage biopharma developing targeted cancer therapies with a proprietary PDC delivery platform.
United States of America CLRB
Cellectis Logo
Develops 'off-the-shelf' CAR T-cell cancer immunotherapies using TALEN® gene-editing.
France ALCLS

Talk to a Data Expert

Have a question? We'll get back to you promptly.